Skip to main content

Closed

TBPH: Theravance Biopharma Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+12.1% / yr

Operating margin0.1%

ROIC0.0%

Financially safe

Stretched

Debt / equity0.25×

Interest coverage0.0×

Current ratio13.14×

Valuation

Unrated

P/E ratio7.4×

Theravance Biopharma Inc

TBPHNASDAQ·USD·Closed

Theravance Biopharma Inc

TBPHNASDAQ·USD·Closed

$16.86

+0.06%

$16.86

+$0.01 (0.06%)

52W Range

59thpctl

Volume

0.59×avg

Mkt Cap

873.82MUSD

P/E

7.4TTM

Div Yield

–ann

52W Range

59thpctl

Volume

0.59×avg

Market Cap

873.82MUSD

P/E Ratio

7.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings